MCPH1 (BRIT1) and outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) harboring EGFR mutations.
M. Rosario Garcia-Campelo
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Susana Benlloch
No relevant relationships to disclose
Jose Javier Sanchez
No relevant relationships to disclose
Carlota Costa
No relevant relationships to disclose
Ana Gimenez Capitan
No relevant relationships to disclose
Jordi Bertran-Alamillo
No relevant relationships to disclose
Clara Mayo
No relevant relationships to disclose
Miguel Angel Molina-Vila
No relevant relationships to disclose
Margarita Majem
No relevant relationships to disclose
Teresa Moran
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Carlos Camps
No relevant relationships to disclose
Dolores Isla
No relevant relationships to disclose
Manuel Cobo
No relevant relationships to disclose
Sara Cros
No relevant relationships to disclose
Laia Capdevila
No relevant relationships to disclose
Enric Carcereny Costa
No relevant relationships to disclose
Santiago Viteri Ramirez
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose